Pulmovant
Pre-clinicalPulmovant is developing innovative therapies, beginning with mosliciguat, to transform the treatment paradigm for people suffering from pulmonary diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Pulmovant is developing innovative therapies, beginning with mosliciguat, to transform the treatment paradigm for people suffering from pulmonary diseases.
Drug Delivery